Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO1F | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | RPS9 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | LGALS3 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | NT5DC1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | NHLRC4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | C10orf128 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | OR2B11 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | GDI2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | SLC2A4 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |